Jorge Maldonado-Hernández

Jorge Maldonado-Hernández


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Gene
Verified
Journal Article
Closed access
RGRaúl Sánchez González
Raúl Sánchez González
MRMaricela Rodríguez-Cruz
Maricela Rodríguez-Cruz
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
FSFiliberto Jasso Saavedra
Filiberto Jasso Saavedra

27 December 2018 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
MLMardia López-Alarcón
Mardia López-Alarcón
PIP. Inda‐Icaza
P. Inda‐Icaza
MMM. C. Márquez‐Maldonado
M. C. Márquez‐Maldonado
AAA. Armenta‐Álvarez
A. Armenta‐Álvarez
LBL. Barbosa‐Cortés
L. Barbosa‐Cortés
JFJ. R. Fernández
J. R. Fernández

1 January 2017 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
GSGabriela E. Saldaña-Dávila
Gabriela E. Saldaña-Dávila
MPMónica I. Piña-Aguero
Mónica I. Piña-Aguero
BNBenjamín A. Núñez-García
Benjamín A. Núñez-García
MLMardia López-Alarcón
Mardia López-Alarcón
Objective. To assess the association between plasma ceramides and hepatic steatosis (HS) in adolescents, independently of obesity. Materials and Methods. Ninety-four adolescents from two previous studies conducted and published by our crew were included. Study subjects were stratified in three groups: normal weight (n=18), obesity (n=34), and obesity + HS (n=42). The presence of HS was defined when ALT/AST ratio was <1. Ceramides subspecies (C14:0, C16:0, C18:0, C24:0, and C24:1) were determined by LC/MS. Results. All ceramides correlated directly with ALT levels and inversely with ALT/AST ratio; the strongest correlation was observed among C14:0 ceramide (r=0.41 and r=-0.54, resp.; P<0.001). Furthermore, significant correlations were observed between cholesterol and all ceramides except for C24:1 ceramide. Interestingly ceramides C14:0, C18:0, and C24:1 correlated directly with both fasting insulin and HOMA-IR index. For assessing HS, a cut-off point of 10.3 nmol/L for C14:0 ceramide reported a sensitivity of 92.7% and a specificity of 73.5% when normal weight and obesity groups (n=52) were compared against obesity + HS group (n=42). Positive and negative predictive values were 77.5% and 90.2%, respectively. Conclusions. Plasma ceramides are closely associated with hepatic steatosis in adolescents. C14:0 ceramide could be a novel biomarker of HS independently of obesity.

17 February 2024 in Archives of Medical Research
Verified
Journal Article
Closed access
AMAlva Belen Morales-Villar
Alva Belen Morales-Villar
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
NÁNelson Eduardo Álvarez-Licona
Nelson Eduardo Álvarez-Licona
MPMónica Ivette Piña-Aguero
Mónica Ivette Piña-Aguero
SVSalvador Villalpando-Hernández
Salvador Villalpando-Hernández
BNBenjamín-Armando Núñez-García
Benjamín-Armando Núñez-García

18 May 2018 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
MPMónica Ivette Piña-Aguero
Mónica Ivette Piña-Aguero
AZAranza Zaldivar-Delgado
Aranza Zaldivar-Delgado
ASAlejandra Salas-Fernández
Alejandra Salas-Fernández
AMAzucena Martínez-Basila
Azucena Martínez-Basila
Mariela Bernabe-GarcíaMariela Bernabe-García
Mariela Bernabe-García
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
The aim of this study was to determine optimal cut-off points for fasting and post-glucose stimulus surrogates of insulin resistance to predict metabolic syndrome in adolescents according to several definitions. One hundred fifty-five adolescents living in Mexico City were enrolled during 2011 and 2012. Waist circumference and blood pressure were recorded. Subjects received an oral glucose load of 1.75 g per kg up to a maximum dose of 75 g. Blood samples were drawn at baseline and 120 minutes. Concentrations of plasma glucose, triglycerides, high-density lipoprotein cholesterol and insulin were determined. The frequency of metabolic syndrome showed a large variability when using a variety of published definitions; in contrast, the optimal cut-off points for fasting insulin, homeostatic model assessment of insulin resistance and two-hour oral glucose tolerance test insulin were very similar in almost all the definitions considered and had adequate diagnostic performance: area under the curve >0.869, sensitivity >0.835 and specificity >0.755. Insulin resistance surrogates had substantial agreements with Ford, Cook and Salas definitions (Kappa~0.62; agreement~82%); moderate agreement was observed for International Diabetes Federation, Cruz and Ferranti definitions (Kappa~0.41–0.59; agreement~77%). Insulin resistance surrogates may be a better approach for metabolic syndrome assessment in an adolescent population because of reduced variability and a higher predictive value.

Verified
Journal Article
Open access
PDF file
MLMardia López-Alarcón
Mardia López-Alarcón
VVVíctor Saúl Vital-Reyes
Víctor Saúl Vital-Reyes
Eduardo Almeida-GutierrezEduardo Almeida-Gutierrez
Eduardo Almeida-Gutierrez
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
SFSalvador Flores-Chávez
Salvador Flores-Chávez
RZRicardo Z’cruz-López
Ricardo Z’cruz-López
Polycystic ovary syndrome (PCOS) is often accompanied with metabolic disturbances attributed to androgen excess and obesity, but the contribution of each has not been defined, and the occurrence of metabolic disturbances is usually not investigated. Ninety-nine women with PCOS and forty-one without PCOS were evaluated. The clinical biomarkers of alterations related to glucose (glucose, insulin, and clamp-derived glucose disposal − M), liver (aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase), and endothelium (arginine, asymmetric dymethylarginine, carotid intima-media thickness, and flow-mediated dilation) metabolism were measured; participants were categorized into four groups according to their obesity (OB) and hyperandrogenemia (HA) status as follows: Healthy (no-HA, lean), HA (HA, lean), OB (no-HA, OB), and HAOB (HA, OB). Metabolic disturbances were very frequent in women with PCOS (≈70%). BMI correlated with all biomarkers, whereas free testosterone (FT) correlated with only glucose- and liver-related indicators. Although insulin sensitivity and liver enzymes were associated with FT, women with obesity showed lower M (coef = 8.56 − 0.080(FT) − 3.71(Ob); p < 0.001) and higher aspartate aminotransferase (coef = 26.27 + 0.532 (FT) + 8.08 (Ob); p = 0.015) than lean women with the same level of FT. Women with obesity showed a higher risk of metabolic disorders than lean women, independent of hyperandrogenemia. Clinicians are compelled to look for metabolic alterations in women with PCOS. Obesity should be treated in all cases, but hyperandrogenemia should also be monitored in those with glucose-or liver-related disturbances.